Active Ingredient(s): Carbidopa, Levodopa & Entacapone
Dosage: 37.5 mg / 150 mg / 200 mg
Form & Pack Size: 30 F.C. Tablets
Indication: Treatment of Parkinson’s disease
Designed for tailored dosing in Parkinson’s management, Parkless 37.5/150/200 mg delivers seamless dopaminergic support. It protects against motor fluctuations, helping patients maintain consistent physical balance and coordination. Advanced neurological therapy crafted for a better quality of life.
Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.
© 2026 Zein Pharma. All rights reserved.
Reviews
There are no reviews yet.